ORYZF - Oryzon Genomics S.A. GAAP EPS of -$0.01 November, 02 2022 07:58 AM Oryzon Genomics S.A. Oryzon Genomics S.A. press release ( OTCPK:ORYZF ): Q3 GAAP EPS of -$0.01. Cash, cash equivalents and marketable securities totaled $27.1 million as of September 30, 2022. For further details see: Oryzon Genomics S.A. GAAP EPS of -$0.01